Position in BMY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,052,649
-$4,486,995 QoQ
Shares Held
52,979
-57.4% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#688
of 2,506 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 20261832 Asset Management L.P. holds $1,536,520,507 across 9 Drug Manufacturers - General names. BMY ranks #8 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
2,162,034 | $549,091,774 | |
| 2 | LLY |
ELI LILLY & Co
|
396,979 | $476,148,561 | |
| 3 | AZN |
Astrazeneca PLC
|
1,215,636 | $230,508,898 | |
| 4 | ABBV |
AbbVie Inc.
|
775,386 | $195,118,133 | |
| 5 | MRK |
Merck & Co., Inc.
|
520,333 | $66,862,790 | |
| 6 | NVS |
Novartis AG
|
51,084 | $8,005,884 | |
| 7 | PFE |
Pfizer Inc
|
235,637 | $5,674,138 | |
| 8 | BMY |
Bristol Myers Squibb Co
This page
|
52,979 | $3,052,649 |
All Filings in BMY
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,052,649 | 52,979 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $7,539,644 | 124,314 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $8,887,531 | 164,767 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,868,678 | 85,780 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,242,247 | 91,645 | Shares | Sole | 2025-08-13 | |
| 2024-06-30 | $41,530 | 1,000 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $4,048,757 | 74,659 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $3,833,421 | 74,711 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $3,407,296 | 58,706 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,341,899 | 52,258 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,666,499 | 52,900 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $3,489,503 | 48,499 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $4,172,556 | 58,694 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,632,475 | 47,175 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $271,671 | 3,720 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $19,952 | 320 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $972,281 | 16,432 | Shares | Sole | 2021-11-15 | |
| 2021-03-31 | $15,729,723 | 249,164 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $36,572,143 | 589,588 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $29,721,040 | 492,968 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $27,289,844 | 464,113 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $15,292,436 | 274,353 | Shares | Sole | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||